Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
暂无分享,去创建一个
A. Rosenwald | R. Greil | H. Eich | V. Diehl | U. Dührsen | M. Dietlein | C. Kobe | J. Zijlstra | P. Borchmann | B. Hertenstein | S. Krause | A. Engert | G. Maschmeyer | A. Lohri | M. Wilhelm | M. Fuchs | A. Viardot | M. Soekler | U. Keller | M. Topp | G. Kuhnert | J. Meissner | B. von Tresckow | C. Baues | M. Vogelhuber | S. Sasse | H. Goergen | J. Thiemer | E. Schäfer
[1] S. Jhawar,et al. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma , 2019, JAMA oncology.
[2] A. Mehnert,et al. Survivors’ perspectives on risks and benefits of Hodgkin lymphoma treatment: results of a survey by the German Hodgkin Study Group , 2018, Leukemia & lymphoma.
[3] J. Damilakis,et al. Second cancer risk assessments after involved‐site radiotherapy for mediastinal Hodgkin lymphoma , 2017, Medical physics.
[4] L. Harrison,et al. Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival. , 2015, International journal of radiation oncology, biology, physics.
[5] A. Levis,et al. The prognostic value of positron emission tomography performed after two courses (INTERIM‐PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL) , 2015, American journal of hematology.
[6] R. Küppers,et al. Hodgkin lymphoma. , 2012, The Journal of clinical investigation.
[7] A. LaCasce,et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. , 2011, Blood.
[8] L. Specht,et al. Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin’s lymphoma: a systematic review , 2010, Haematologica.
[9] M. D. De Bruin,et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. , 2008, Journal of the National Cancer Institute.
[10] Michel Meignan,et al. Report on the First International Workshop on interim-PET scan in lymphoma , 2009, Leukemia & lymphoma.
[11] A. Horwich,et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. , 2007, Journal of the National Cancer Institute.
[12] E. Noordijk,et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] J. Young,et al. What are the information priorities for cancer patients involved in treatment decisions? An experienced surrogate study in Hodgkin's disease. , 1996, British Journal of Cancer.